In its Q2 2026 investor letter, Alger Small Cap Focus Fund highlighted GeneDx Holdings Corp. (NASDAQ:WGS). GeneDx Holdings Corp. (NASDAQ:WGS) is a genomics company that offers advanced exome and genome sequencing for pediatric and rare disease diagnostics. On July 20, 2026, GeneDx Holdings Corp. (NASDAQ:WGS) closed at $60.65 per share, reflecting a market capitalization of $1.80 billion. GeneDx Holdings Corp. (NASDAQ:WGS) posted a one-month return of 4.42%, while its shares lost 25.03% over the past 52 weeks. Alger Small Cap Focus Fund stated the following regarding GeneDx Holdings Corp. (NASDAQ:WGS) in its Q2 2026 investor update: